ConductScience.org, home

Gene · 1441

Papers3,351

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

121 to 140 of 3,351

Download this page as JSON
TitleJournalYearPMIDFound bySource
Early Neutrophil Activation in Psoriatic Skin at Relapse Following Dead Sea Climatotherapy.Exp Dermatol202540181552PubTator, text miningPubMed
CSF3R-AS promotes hepatocellular carcinoma progression and sorafenib resistance through the CSF3R/JAK2/STAT3 positive feedback loop.Cell Death Dis202540155591PubTator, text miningPubMed
Prognostic analysis and identification of M7G immune-related genes in lung squamous cell carcinoma.Front Immunol202540098956PubTator, text miningPubMed
TEDML: a new machine learning (ML) approach for predicting thyroid eye disease and identifying key biomarkers.J Endocrinol202540028837PubTator, text miningPubMed
Predicting interactome networks of up/down regulated proteins and drug-gene interaction analysis associated with peri-implantitis.Dent Res J (Isfahan)202540028501PubTator, text miningPubMed
Spatial transcriptomics reveals prognostically LYZ+ fibroblasts and colocalization with FN1+ macrophages in diffuse large B-cell lymphoma.Cancer Immunol Immunother202539998673PubTator, text miningPubMed
Colony-stimulating factor 3 and its receptor promote leukocyte immunoglobulin-like receptor B2 expression and ligands in gastric cancer.World J Gastrointest Oncol202539958563PubTator, text miningPubMed
CSF3R Mutations in Hematological Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.Am J Hematol202539950584PubTator, text miningPubMed
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia.Ann Hematol202539907800PubTator, text miningPubMed
G-CSF modulates innate and adaptive immunity via the ligand-receptor pathway of binding GCSFR in flounder (Paralichthys olivaceus).Fish Shellfish Immunol202539880324PubTator, text miningPubMed
Chronic Neutrophilic Leukemia: Advances in Diagnosis, Genetic Insights, and Management Strategies.Cancers (Basel)202539858009PubTator, text miningPubMed
Dual ASXL1 and CSF3R mutations drive myeloid-biased stem cell expansion and enhance neutrophil differentiation.Blood Adv202539777477PubTator, text miningPubMed
Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients: a multicenter study by ESID and EBMT IEWP.Blood Adv202539775668PubTator, text miningPubMed
Differentiating multiple sclerosis with predominant spinal cord and optic nerve involvement from other autoimmune demyelinating diseases using B cell immunophenotyping and gene expression profiling.Mult Scler Relat Disord202539729902PubTator, text miningPubMed
Deep mutational scanning-guided design of a high-affinity helix-loop-helix peptide targeting G-CSF receptor.Bioorg Med Chem Lett202539667506PubTator, text miningPubMed
A new severe congenital neutropenia syndrome associated with autosomal recessive COPZ1 mutations.Blood202539642330PubTator, text miningPubMed
Elucidating the Role of Autophagy-related Genes in Polycystic Ovary Syndrome: Implications for Diagnostic Models and Immune Response Regulation.Curr Med Chem202539421991PubTator, text miningPubMed
Identification and Validation of Oxidative Stress-Related Biomarkers for Bronchopulmonary Dysplasia.Mol Biotechnol202539292413PubTator, text miningPubMed
Differentiation of Acute Leukemia Cells Including Cells with MLL-AF4 Rearrangements Induced by Jiyuan Oridonin A.Recent Pat Anticancer Drug Discov202538204268PubTator, text miningPubMed
CSF3R Gln776X and ASXL1 mutations in multiple myeloma associated with chronic neutrophilic leukemia: case report and literature review.Arch Med Sci202439967925PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/1441/papers?page=7